Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nath Bio-Genes (India)BOM:537291 -0.91%71 5-Year Yield-on-Cost % is 1.31 as of Sep. 07, 2026, which is 15% above its 10-year median of 1.14. GuruFocus rates BOM:537291 with a GF Score™ of 71/100 and a GF Value™ of ₹262.74 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 144 Agriculture companies, Nath Bio-Genes (India) ranks worse than 69.44% on this metric.
Nath Bio-Genes (India)'s yield on cost for the quarter that ended in Jun. 2026 was 1.31.
The historical rank and industry rank for Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % or its related term are showing as below:
BOM:537291'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.61 Med: 1.14 Max: 2.42
Current: 1.31
During the past 13 years, Nath Bio-Genes (India)'s highest Yield on Cost was 2.42. The lowest was 0.61. And the median was 1.14.
BOM:537291's 5-Year Yield-on-Cost % is ranked worse than 69.44% of 144
companies
in the Agriculture industry
Industry Median: 3.065
vs BOM:537291: 1.31
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Nath Bio-Genes (India) 5-Year Yield-on-Cost % Related Terms
BOM:537291 vs CTVA, CF, MOS: 5-Year Yield-on-Cost % Comparison
For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nath Bio-Genes (India) 5-Year Yield-on-Cost % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Nath Bio-Genes (India) (BOM:537291) has a 5-Year Yield-on-Cost % of 1.31 as of Sep. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nath Bio-Genes (India) and its competitors. This is 15% above median its historical median of 1.14. Over the past decade, Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % has ranged from 0.61 to 2.42. According to the industry distribution chart, Nath Bio-Genes (India) ranks #100 out of 144 companies in the Agriculture industry, placing it in the top 69.4%.
Is Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % too high?
Nath Bio-Genes (India)'s current 5-Year Yield-on-Cost % of 1.31 is 15% above median its 10-year median of 1.14. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 2.42. The Agriculture industry median 5-Year Yield-on-Cost % is 3.07. Nath Bio-Genes (India)'s value of 1.31 is 57.3% below this industry median. Based on the distribution chart, Nath Bio-Genes (India) ranks #100 out of 144 companies in the Agriculture industry, which is below the industry midpoint. Overall, Nath Bio-Genes (India) has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s 5-Year Yield-on-Cost % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Nath Bio-Genes (India) ranks #100 out of 144 companies for 5-Year Yield-on-Cost %. This places Nath Bio-Genes (India) in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.07. Nath Bio-Genes (India)'s value of 1.31 is 57.3% below this benchmark. Historically, Nath Bio-Genes (India)'s own 5-Year Yield-on-Cost % has ranged from 0.61 to 2.42 over the past decade. While the company's 10-year median is 1.14 vs. the industry median of 3.07, Nath Bio-Genes (India) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Agriculture company?
The median 5-Year Yield-on-Cost % among Agriculture companies is 3.07, based on 144 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nath Bio-Genes (India)'s current 5-Year Yield-on-Cost % of 1.31 is 57.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nath Bio-Genes (India) and its competitors. For the Agriculture industry, the median 5-Year Yield-on-Cost % is 3.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nath Bio-Genes (India)'s current 5-Year Yield-on-Cost % is 1.31, which is 15% above median its own 10-year median of 1.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹262.74, compared to a current price of ₹152.55 — trading 41.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.31, which is 15% above median its 10-year median of 1.14 and 57.3% below the Agriculture industry median of 3.07. Nath Bio-Genes (India)'s overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current 5-Year Yield-on-Cost % is 1.31 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?
Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued.
The current stock price of ₹152.55 is trading 41.9% below its estimated GF Value™ of ₹262.74.
GuruFocus considers Nath Bio-Genes (India) to be Significantly Undervalued.
Key valuation signals for BOM:537291:
5-Year Yield-on-Cost %: 1.31 (15% above median its 10-year median of 1.14)
GF Value™: ₹262.74 vs. price of ₹152.55 (41.9% below fair value)
Industry Position: 57.3% below the Agriculture median (#100 of 144)
No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
71GF Score
Get the complete analysis for BOM:537291
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537291 has been successfully added to your 
